WW International推出礼来公司新型口服GLP-1药物Foundayo® 可通过Lillydirect平台获取

美股速递
Apr 09

WW International, Inc.宣布正式引入礼来公司研发的新型口服GLP-1类药物Foundayo®,该药物现可通过礼来旗下数字健康服务平台Lillydirect进行供应。此举标志着WW在医疗健康服务领域的战略拓展,为消费者提供更便捷的创新疗法获取渠道。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10